Harmony Biosciences Holdings
Harmony Biosciences Holdings57
About
What does Harmony Biosciences Holdings do?
Harmony Biosciences Holdings is a biopharmaceutical company dedicated to addressing unmet medical needs in rare neurological diseases. Their primary focus is on developing and commercializing therapies for conditions such as narcolepsy. They aim to improve the lives of patients by providing novel treatment options.
What is Harmony Biosciences Holdings's revenue?
StartupHub estimates Harmony Biosciences Holdings's annual revenue at $104.3M (range $56.2M to $186.1M, 64% confidence), based on comparable companies in the sector.
What is Harmony Biosciences Holdings's valuation?
StartupHub estimates Harmony Biosciences Holdings's effective valuation at $1.7B (range $1.0B to $2.4B, 10% confidence), based on comparable companies in the sector.
How much funding has Harmony Biosciences Holdings raised?
Harmony Biosciences Holdings has raised a total of $401M in funding. The most recent round on record is IPO.
Where is Harmony Biosciences Holdings headquartered?
Harmony Biosciences Holdings is headquartered in Plymouth Meeting, United States.
When was Harmony Biosciences Holdings founded?
Harmony Biosciences Holdings was founded in 2017.
What industry does Harmony Biosciences Holdings operate in?
Harmony Biosciences Holdings operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Neurology.
How many employees does Harmony Biosciences Holdings have?
Harmony Biosciences Holdings has approximately 332 people on record.
No comments yet. Be the first to share your take.